These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

684 related articles for article (PubMed ID: 27446086)

  • 1. Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.
    Söderberg D; Segelmark M
    Front Immunol; 2016; 7():256. PubMed ID: 27446086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil Extracellular Traps Contain Selected Antigens of Anti-Neutrophil Cytoplasmic Antibodies.
    Panda R; Krieger T; Hopf L; Renné T; Haag F; Röber N; Conrad K; Csernok E; Fuchs TA
    Front Immunol; 2017; 8():439. PubMed ID: 28450870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
    Söderberg D; Kurz T; Motamedi A; Hellmark T; Eriksson P; Segelmark M
    Rheumatology (Oxford); 2015 Nov; 54(11):2085-94. PubMed ID: 26170375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal conformation and impaired degradation of propylthiouracil-induced neutrophil extracellular traps: implications of disordered neutrophil extracellular traps in a rat model of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Nakazawa D; Tomaru U; Suzuki A; Masuda S; Hasegawa R; Kobayashi T; Nishio S; Kasahara M; Ishizu A
    Arthritis Rheum; 2012 Nov; 64(11):3779-87. PubMed ID: 22777766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive neutrophil extracellular trap formation in ANCA-associated vasculitis is independent of ANCA.
    Kraaij T; Kamerling SWA; van Dam LS; Bakker JA; Bajema IM; Page T; Brunini F; Pusey CD; Toes REM; Scherer HU; Rabelink TJ; van Kooten C; Teng YKO
    Kidney Int; 2018 Jul; 94(1):139-149. PubMed ID: 29606398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Masuda S; Nonokawa M; Futamata E; Nishibata Y; Iwasaki S; Tsuji T; Hatanaka Y; Nakazawa D; Tanaka S; Tomaru U; Kawakami T; Atsumi T; Ishizu A
    Am J Pathol; 2019 Apr; 189(4):839-846. PubMed ID: 30677396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-neutrophil extracellular trap antibody in a patient with relapse of anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report.
    Shida H; Hashimoto N; Kusunoki Y; Hattanda F; Ogawa Y; Hayashi T; Nakazawa D; Masuda S; Tomaru U; Ishizu A
    BMC Nephrol; 2018 Jun; 19(1):145. PubMed ID: 29929470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Neutrophils in ANCA-Associated Vasculitis: The Pathogenic Role and Diagnostic Utility of Autoantibodies.
    Walulik A; Łysak K; Błaszkiewicz M; Górecki I; Gomułka K
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidylarginine Deiminase Inhibitor Suppresses Neutrophil Extracellular Trap Formation and MPO-ANCA Production.
    Kusunoki Y; Nakazawa D; Shida H; Hattanda F; Miyoshi A; Masuda S; Nishio S; Tomaru U; Atsumi T; Ishizu A
    Front Immunol; 2016; 7():227. PubMed ID: 27375623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation.
    Ma YH; Ma TT; Wang C; Wang H; Chang DY; Chen M; Zhao MH
    Arthritis Res Ther; 2016 Jan; 18():2. PubMed ID: 26739852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis.
    Hilhorst M; van Paassen P; Tervaert JW;
    J Am Soc Nephrol; 2015 Oct; 26(10):2314-27. PubMed ID: 25956510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of NETs in ANCA-associated vasculitis.
    Shiratori-Aso S; Nakazawa D
    Front Immunol; 2023; 14():1261151. PubMed ID: 37781373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps.
    Huang YM; Wang H; Wang C; Chen M; Zhao MH
    Arthritis Rheumatol; 2015 Oct; 67(10):2780-90. PubMed ID: 26097236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANCA-associated vasculitis: diagnostic and therapeutic strategy.
    Ozaki S
    Allergol Int; 2007 Jun; 56(2):87-96. PubMed ID: 17460438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis.
    Takeda S; Watanabe-Kusunoki K; Nakazawa D; Kusunoki Y; Nishio S; Atsumi T
    Front Immunol; 2019; 10():1334. PubMed ID: 31249574
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update.
    Gómez-Puerta JA; Bosch X
    Am J Pathol; 2009 Nov; 175(5):1790-8. PubMed ID: 19815703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis.
    Nakazawa D; Masuda S; Tomaru U; Ishizu A
    Nat Rev Rheumatol; 2019 Feb; 15(2):91-101. PubMed ID: 30542206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil extracellular traps can activate alternative complement pathways.
    Wang H; Wang C; Zhao MH; Chen M
    Clin Exp Immunol; 2015 Sep; 181(3):518-27. PubMed ID: 25963026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis.
    Flint SM; McKinney EF; Smith KG
    Curr Opin Rheumatol; 2015 Mar; 27(2):197-203. PubMed ID: 25629443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.